Frontlight ResearchEarly access
Trial site
UNC Hospitals, The University of North Carolina at Chapel Hill
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Melanoma4 trials
- Acute myeloid leukaemia2 trials
- Lung cancer2 trials
- Pancreatic cancer2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Primary biliary cholangitis1 trial
- Phase
- Phase 33 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting4 trials
- Terminated3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Gilead Sciences2 trials
- Pfizer2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Immatics US, Inc.1 trial
- Iovance Biotherapeutics, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma3 recruiting
- Bladder cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Terminated
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026